Effectiveness Of Transdiagnostic Treatment On Craving, Depression, Anxiety, Emotion Dysregulation, And Impulsivity

Effectiveness of Transdiagnostic Treatment on Craving, Depression, Anxiety, Emotion Dysregulation, and Impulsivity in Patients with Methadone Maintenance Treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191109045381N1

Enrollment

Registered

2020-01-18

Start date

2019-11-11

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Substance Use Disorder. Condition 2: Depression. Condition 3: Anxiety. Other psychoactive substance abuse Neonatal Cerebral Depression Anxiety disorder due to known physiological condition

Interventions

Intervention 1: Intervention group: transdiagnostic treatment . Includes 12 sessions of group therapy. Intervention 2: Control group: No intervention.

Eligibility

Sex/Gender

Male

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Male Gender Membership In Substance Abuse Clinics Moderate Severity Of Symptoms Of Depression And Anxiety Education At Least Third Guidance Eighteen Years Of Age

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Craving. Timepoint: The Beginning And The End of The Study. Method of measurement: Craving Questionnaire.	—

Secondary

Measure	Time frame
Dysregulation emotion. Timepoint: The Beginning And The End of The Study. Method of measurement: DERS.;Impulsivity. Timepoint: The Beginning And The End of The Study. Method of measurement: BIS.;Depression. Timepoint: The Beginning And The End of The Study. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: The Beginning And The End of The Study. Method of measurement: Beck Anxiety Inventory.	—

Measure

Time frame

Dysregulation emotion. Timepoint: The Beginning And The End of The Study. Method of measurement: DERS.;Impulsivity. Timepoint: The Beginning And The End of The Study. Method of measurement: BIS.;Depression. Timepoint: The Beginning And The End of The Study. Method of measurement: Beck Depression Inventory.;Anxiety. Timepoint: The Beginning And The End of The Study. Method of measurement: Beck Anxiety Inventory.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFardin Tahmasbi

The University Of Kurdestan

F.tahmasabi@hum.uok.ac.ir+98 87 3522 1592

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026